Stimcell Energetics (STME) Cash & Equivalents (2011 - 2026)
Stimcell Energetics' (STME) quarterly Cash & Equivalents came in at $10257.0 in Q1 2026, up 53.59% year-on-year from $6678.0 in Q1 2025, and down 77.78% quarter-over-quarter from $46159.0 in Q4 2025.
Stimcell Energetics (STME) Cash & Equivalents (2011 - 2026) Analysis & Trends
Stimcell Energetics' Cash & Equivalents history runs 15 years deep, the most recent figure standing at $10257.0 for Q1 2026.
- On a quarterly basis, Cash & Equivalents rose 53.59% year-over-year to $10257.0 in Q1 2026; TTM through Feb 2026 was $10257.0, a 53.59% increase from a year earlier, with the FY2025 full-year figure at $14581.0, down 66.41% from the prior year.
- Cash & Equivalents retreated to $10257.0 in Q1 2026 per STME's latest filing, from $46159.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $98295.0 in Q2 2023 and bottomed at $6437.0 in Q3 2025.
- The 5-year median for Cash & Equivalents is $22623.0 (2023), against an average of $31220.4.
- Across the five-year window, Cash & Equivalents soared 944.53% in 2024 and sank 91.62% in 2025, its largest moves.
- Year by year, Cash & Equivalents stood at $17813.0 in 2022, then rose by 27.0% to $22623.0 in 2023, then soared by 49.5% to $33821.0 in 2024, then jumped by 36.48% to $46159.0 in 2025, then tumbled by 77.78% to $10257.0 in 2026.
- Per Business Quant, the three latest STME Cash & Equivalents figures stand at $10257.0 (Q1 2026), $46159.0 (Q4 2025), and $6437.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | 10,257.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 10,257.00 |
| Nov 30, 2025 | 46,159.00 |
| Aug 31, 2025 | 6,437.00 |
| May 31, 2025 | 14,581.00 |
| Feb 28, 2025 | 6,678.00 |
| Nov 30, 2024 | 33,821.00 |
| Aug 31, 2024 | 20,552.00 |
| May 31, 2024 | 43,415.00 |
| Feb 29, 2024 | 79,677.00 |
| Nov 30, 2023 | 22,623.00 |
| Aug 31, 2023 | 58,074.00 |
| May 31, 2023 | 98,295.00 |
| Feb 28, 2023 | 7,628.00 |
| Nov 30, 2022 | 17,813.00 |
| Aug 31, 2022 | 9,620.00 |
| May 31, 2022 | 24,380.00 |
| Feb 28, 2022 | 30,736.00 |
| Nov 30, 2021 | 37,147.00 |
| Aug 31, 2021 | 63,772.00 |
| May 31, 2021 | 20,753.00 |